AbbVie's New Crohn's Disease Drug Candidate
Galapagos and AbbVie's experimental Crohn's disease drug GLPG0634 is entering a phase 2 clinical study.
Categories: Uncategorized Tags: clinical-study, crohn, disease-drug
Cattle disease bacteria widespread in the UK
A new study has found that bacteria responsible for chronic intestinal inflammation in cattle, which have also been implicated in Crohn's disease in humans, are widespread in the UK countryside.
Categories: Uncategorized Tags: also-been, are-widespread, crohn, for-chronic, has-found, intestinal-inflammation, new-study-, which-have
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
First selective JAK1 inhibitor to enter Phase 2 studies in Crohn`s disease Galapagos to fund and complete Phase 2 study; AbbVie to pay Galapagos $50 million upon successful completion, expected in 2015 …
Categories: Uncategorized Tags: 2015-, crohn, fund-and, galapagos, million-upon, phase, successful-completion
PET/CT may enhance detection of inflammatory bowel diseases in the future
Inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, may be detected and monitored more effectively in the future with positron emission tomography/computed tomography, according to research published in the May issue of The Journal of Nuclear Medicine.
Categories: Uncategorized Tags: bowel-diseases-, crohn, detected-and, disease-and, emission-tomography, future, journal, monitored-more, nuclear, research-published, the-future, ulcerative-colitis, with-positron
Bel Marra Health Reports on One Man’s Story: New York Man Says He Has Found a “Cure” for His Crohn’s Disease
Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on new research outlining one man’s story of how he has “cured” his Crohn’s Disease .Toronto, ON (PRWEB) April 05, 2013 Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on new research outlining one man’s story of how …
Categories: Uncategorized Tags: april, crohn, how, marra, marra-health, new-research-, outlining-one, prweb, reporting-on-new, specially-formulated
Experts outline new agenda for inflammatory bowel disease research
Every five years, the Crohn’s & Colitis Foundation of America gathers top researchers in inflammatory bowel disease to set the research agenda for the next five years.
Categories: Uncategorized Tags: a-for-the, a-gathers-top, america, bowel-disease, colitis, crohn, five-years, for-the, gathers-top, research-agenda, set-the
Research and Markets: EpiCast Report: Crohn’s Disease Epidemiology Forecast to 2022
Research and Markets has announced the addition of a new report “EpiCast Report: Crohn’s Disease Epidemiology For
Categories: Uncategorized Tags: a-new-report, addition, announced-the-addition, crohn, disease, disease-epidemiology, has-announced, markets, new-report, report
Curing Chron’s Disease ?
Ari Meisel was taking 16 pills a day in order to manage his Crohn’s disease – a chronic, inflammatory autoimmune disease affecting the gastrointestinal (GI) tract.
Categories: Uncategorized Tags: affecting-the, autoimmune-disease, crohn, gastrointestinal, manage-his, meisel
Qu Biologics Launches Treatment Trial for Crohn’s Disease
Canadian participants are being sought for a new Health Canada-approved clinical trial for the treatment of Crohn’s disease , the Vancouver-based biopharmaceutical company Qu Biologics announced today.
Categories: Uncategorized Tags: announced-today, are-being, biologics, clinical-trial, crohn, for-the, health, sought-for, treatment, vancouver, vancouver-based
Manchester leads new international study investigating Inflammatory Bowel Disease
( University of Manchester ) The University of Manchester is leading a 12 million systems medicine research network to identify better treatments for Inflammatory Bowel Disease like Crohn's Disease.
Categories: Uncategorized Tags: bowel-disease, crohn, disease, identify-better, inflammatory, manchester, medicine-research, million-systems, treatments-for, university-